A 52-year-old man with mild COVID-19 infection managed in the community asks about antiviral treatment. He is fully vaccinated and has no comorbidities. Symptoms are fever, cough and myalgia; oxygen saturation is 98% on room air. According to Australian guidance, what is the most appropriate management?